Vaccine peptides elicit PD‑L1–specific CD8+ (and CD4+) T cells; these CTLs recognize PD‑L1–derived peptides presented on MHC of PD‑L1–expressing cells and kill them via perforin/granzyme-mediated cytolysis, not by a direct drug effect.